These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 30646517)

  • 1. G-Protein Coupled Estrogen Receptor in Breast Cancer.
    Hsu LH; Chu NM; Lin YF; Kao SH
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30646517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER.
    Zekas E; Prossnitz ER
    BMC Cancer; 2015 Oct; 15():702. PubMed ID: 26470790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
    Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
    J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The G-protein-coupled estrogen receptor, a gene co-expressed with ERα in breast tumors, is regulated by estrogen-ERα signalling in ERα positive breast cancer cells.
    Pal U; Manjegowda MC; Singh N; Saikia S; Philip BS; Jyoti Kalita D; Kumar Rai A; Sarma A; Raphael V; Modi D; Chandra Kataki A; Mukund Limaye A
    Gene; 2023 Aug; 877():147548. PubMed ID: 37279863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two novel GPER agonists induce gene expression changes and growth effects in cancer cells.
    Lappano R; Rosano C; Santolla MF; Pupo M; De Francesco EM; De Marco P; Ponassi M; Spallarossa A; Ranise A; Maggiolini M
    Curr Cancer Drug Targets; 2012 Jun; 12(5):531-42. PubMed ID: 22414008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells.
    Rigiracciolo DC; Santolla MF; Lappano R; Vivacqua A; Cirillo F; Galli GR; Talia M; Muglia L; Pellegrino M; Nohata N; Di Martino MT; Maggiolini M
    J Exp Clin Cancer Res; 2019 Feb; 38(1):58. PubMed ID: 30728047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamoxifen induces toxicity, causes autophagy, and partially reverses dexamethasone resistance in Jurkat T cells.
    Torres-López L; Maycotte P; Liñán-Rico A; Liñán-Rico L; Donis-Maturano L; Delgado-Enciso I; Meza-Robles C; Vásquez-Jiménez C; Hernández-Cruz A; Dobrovinskaya O
    J Leukoc Biol; 2019 May; 105(5):983-998. PubMed ID: 30645008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NHERF1 inhibits proliferation of triple-negative breast cancer cells by suppressing GPER signaling.
    Wang Y; Peng Z; Meng R; Tao T; Wang Q; Zhao C; Liu H; Song R; Zheng J; Qin Q; He J
    Oncol Rep; 2017 Jul; 38(1):221-228. PubMed ID: 28535016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ER-mediated anti-tumor effects of shikonin on breast cancer.
    Yang Y; Gao W; Tao S; Wang Y; Niu J; Zhao P; Rao C; Yang L
    Eur J Pharmacol; 2019 Nov; 863():172667. PubMed ID: 31545985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 17β-estradiol-induced growth of triple-negative breast cancer cells is prevented by the reduction of GPER expression after treatment with gefitinib.
    Girgert R; Emons G; Gründker C
    Oncol Rep; 2017 Feb; 37(2):1212-1218. PubMed ID: 27959426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GPER Promoter Methylation Controls GPER Expression in Breast Cancer Patients.
    Weissenborn C; Ignatov T; Nass N; Kalinski T; Dan Costa S; Zenclussen AC; Ignatov A
    Cancer Invest; 2017 Feb; 35(2):100-107. PubMed ID: 28118074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Androgen Receptor Promotes Cellular Proliferation by Suppression of G-Protein Coupled Estrogen Receptor Signaling in Triple-Negative Breast Cancer.
    Shen Y; Yang F; Zhang W; Song W; Liu Y; Guan X
    Cell Physiol Biochem; 2017; 43(5):2047-2061. PubMed ID: 29059676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.
    Santolla MF; Avino S; Pellegrino M; De Francesco EM; De Marco P; Lappano R; Vivacqua A; Cirillo F; Rigiracciolo DC; Scarpelli A; Abonante S; Maggiolini M
    Cell Death Dis; 2015 Jul; 6(7):e1834. PubMed ID: 26225773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPER functions as a tumor suppressor in triple-negative breast cancer cells.
    Weißenborn C; Ignatov T; Ochel HJ; Costa SD; Zenclussen AC; Ignatova Z; Ignatov A
    J Cancer Res Clin Oncol; 2014 May; 140(5):713-23. PubMed ID: 24553912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer Cells.
    Lappano R; Mallet C; Rizzuti B; Grande F; Galli GR; Byrne C; Broutin I; Boudieu L; Eschalier A; Jacquot Y; Maggiolini M
    Cells; 2019 Jun; 8(6):. PubMed ID: 31207943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Function of G-Protein-Coupled Estrogen Receptor-1 in Reproductive System Tumors.
    Qian H; Xuan J; Liu Y; Shi G
    J Immunol Res; 2016; 2016():7128702. PubMed ID: 27314054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase inhibitors down-regulate G-protein-coupled estrogen receptor and the GPER-antagonist G-15 inhibits proliferation in endometriotic cells.
    Imesch P; Samartzis EP; Dedes KJ; Fink D; Fedier A
    Fertil Steril; 2013 Sep; 100(3):770-6. PubMed ID: 23755949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptors as potential therapeutic target in endometrial cancer.
    Guha P; Sen K; Chowdhury P; Mukherjee D
    J Recept Signal Transduct Res; 2023 Feb; 43(1):19-26. PubMed ID: 36883690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estetrol/GPER/SERPINB2 transduction signaling inhibits the motility of triple-negative breast cancer cells.
    Cirillo F; Spinelli A; Talia M; Scordamaglia D; Santolla MF; Grande F; Rizzuti B; Maggiolini M; Gérard C; Lappano R
    J Transl Med; 2024 May; 22(1):450. PubMed ID: 38741146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activation of G protein-coupled receptor 30 (GPR30) inhibits proliferation of estrogen receptor-negative breast cancer cells in vitro and in vivo.
    Wei W; Chen ZJ; Zhang KS; Yang XL; Wu YM; Chen XH; Huang HB; Liu HL; Cai SH; Du J; Wang HS
    Cell Death Dis; 2014 Oct; 5(10):e1428. PubMed ID: 25275589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.